Amber Cote, MA, LPC Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 19 S Walnut St, Suite D, Wauregan, CT 06387 Phone: 860-771-9989 |
News Archive
Now, an intriguing preprint research paper on the bioRxiv server reports the identification of an enzyme called chitinase 3-like-1 (CHI3L1) that mediates this age-dependent impact of the virus and could serve as a powerful therapeutic approach in mitigating the severity of COVID-19 in this high-risk group.
"Reducing commodity costs for antiretroviral drugs by a mere five to 10 percent can represent hundreds of millions of dollars in savings for the global community. In turn these savings translate into millions of more patients who can receive access to life-saving treatment," David de Ferranti, president of Results for Development Institute (R4D), and Kanika Bahl, managing director at R4D, write in a Huffington Post opinion piece.
President Obama in his weekly radio and Internet address on Saturday said that he would nominate former New York City Health Commissioner Margaret Hamburg as FDA commissioner and Baltimore Health Commissioner Joshua Sharfstein as the agency's principal deputy commissioner, the New York Times reports (Harris, New York Times, 3/15).
Syapse, the leader in precision medicine software, has completed the first close of a $25 million Series C funding round. The financing round is being led by Ascension Ventures, a subsidiary of Ascension, the nation's largest non-profit and Catholic health system.
Tobacco is a known risk factor for the misuse of prescription opioids. In addition, concurrent use of opioids and sedative-hypnotics is a risk factor for opioid overdose or addiction.
› Verified 4 days ago